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Abstract
Background: Although the previous study demonstrated the envelope protein of dengue viruses
is under purifying selection pressure, little is known about the genetic differences of full-length viral
genomes of DENV-3. In our study, complete genomic sequencing of DENV-3 strains collected from
different geographical locations and isolation years were determined and the sequence diversity as
well as selection pressure sites in the DENV genome other than within the E gene were also
analyzed.
Results: Using maximum likelihood and Bayesian approaches, our phylogenetic analysis revealed
that the Taiwan's indigenous DENV-3 isolated from 1994 and 1998 dengue/DHF epidemics and one
1999 sporadic case were of the three different genotypes – I, II, and III, each associated with DENV-
3 circulating in Indonesia, Thailand and Sri Lanka, respectively. Sequence diversity and selection
pressure of different genomic regions among DENV-3 different genotypes was further examined
to understand the global DENV-3 evolution. The highest nucleotide sequence diversity among the
fully sequenced DENV-3 strains was found in the nonstructural protein 2A (mean ± SD: 5.84 ±
0.54) and envelope protein gene regions (mean ± SD: 5.04 ± 0.32). Further analysis found that
positive selection pressure of DENV-3 may occur in the non-structural protein 1 gene region and
the positive selection site was detected at position 178 of the NS1 gene.
Conclusion: Our study confirmed that the envelope protein is under purifying selection pressure
although it presented higher sequence diversity. The detection of positive selection pressure in the
non-structural protein along genotype II indicated that DENV-3 originated from Southeast Asia
needs to monitor the emergence of DENV strains with epidemic potential for better epidemic
prevention and vaccine development.
Background
Dengue fever (DF) and its more severe forms, dengue
hemorrhagic fever (DHF) and dengue shock syndrome
(DSS), have emerged as major public health problems in
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tropical and subtropical areas [1,2]. Infection with dengue
viruses (DENV), which are maintained in a human-mos-
quito transmission cycle involving primarily Aedes aegypti
and Aedes albopictus, can result in various clinical manifes-
tations ranging from asymptomatic to DF, DHF, DSS and
death [3]. The occurrences of dengue epidemics in the
past 30 years have been characterized by the rising inci-
dence rates of infection and continuous expansion in geo-
graphic distribution of DHF epidemics [4]. Importantly,
the epidemics of DHF have become progressively larger in
the last 20 years in many dengue endemic countries [5].
The increasingly widespread distribution and the rising
incidence of DF and DHF are related to increased distribu-
tion of A. aegypti, global urbanization and rapid and fre-
quent international travel.
Epidemiological analysis reveals that some DENV strains
are associated with mild epidemics with low occurrences
of DHF cases and inefficient virus transmission, whereas
others are more likely to cause severe epidemics with high
incidence of DHF/DSS and rapid virus transmission [6,7].
The large DHF epidemics in Indonesia in the 1970s and
Sri Lanka after 1989 provided evidence supporting this
phenomenon [8,9]. Dengue virus serotype 3 (DENV-3)
re-appeared in Latin Americain 1994 after its absence for
seventeen years. The virus was detected initially in Pan-
ama and soon dispersed throughout Central and South
America during the following years [10,11]. This introduc-
tion coincided with an increased number of DHF cases in
this region. Although the genotype originating in South-
east Asia has been postulated as the major cause of the
increased virulence, the molecular marker associated with
a difference in virulence among genotypes at the full-
genomic level is still largely unknown.
Dengue is caused by four antigenically related but geneti-
cally distinct viruses (DENV-1, -2, -3 and -4) belonging to
the genus Flavivirus, family Flaviviridae [12]. DENV is a
single stranded, positive-sense RNA virus, approximately
10,700 nucleotides in length. The genome contains a sin-
gle open reading frame (ORF) that encodes a polyprotein,
which is co- and post-translationally processed to produce
three structural proteins, including capsid (C), pre-mem-
brane (prM) and envelope (E), and seven nonstructural
(NS) proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B and
NS5) [12,13]. A considerable number of studies have
revealed that each serotype of DENV is composed of phy-
logenetically distinct clusters that have been classified into
"genotypes" or "subtypes," and each genotype is also
composed of phylogenetically distinct "groups" or
"clades." A previous study has classified DENV-3 strains
into four genotypes based on limited numbers of nucleic
acid sequences from the prM and E protein genes [6];
DENV-3 strains have also been re-classified into five gen-
otypes [14]. Growing evidence suggests the existence of
DENV strains with different epidemic potentials. This evi-
dence is supported by the following observations: (1) the
differences in fitness among various genotypes of DENV-
2 reflect their different replication capabilities in human
monocytes and dendritic cells [15]; (2) around 1991,
clade replacement among DENV-3 genotype II containing
isolates from Thailand was associated with changing sero-
type prevalence and incidence of DHF epidemics [16];
and (3) sudden changes in the genotype of DENV at a sin-
gle locality have been observed that appeared to originate
from the genetic bottleneck of a large viral population
[14,17]. This sudden genotype replacement has been
associated with more severe DHF epidemics in Indonesia
and Sri Lanka [9,18]. However, most of these studies
involved the E gene alone. This raises an important ques-
tion: Is the introduction of different DENV genotypes in
disparate geographical locations a result of sequence dif-
ferences outside of the E gene altering their epidemic
potential, or it is simply a stochastic event in viral evolu-
tion?
Dengue epidemics in Taiwan are usually initiated by
imported index cases (King et al., 2000). The re-emer-
gence of dengue outbreaks in Taiwan started when DENV-
2 was re-introduced into the off-islet of Hsiao-Liu-Chiu in
1981. In 1987–1988, another large-scale DENV-1 out-
break occurred in Kaohsiung and Pingtung in southern
Taiwan [19]. Although DENV-3 was detected sporadically
from imported index cases, no DENV-3-related epidemic
occurred until 11 DHF cases were confirmed in Kaohsiung
in 1994 and 23 DHF cases in Tainan in 1998 [20]. Taiwan
neighbors many Southeast Asian countries and more than
25,000 travelers visit these adjacent countries annually.
The surveillance system implemented by the Center for
Disease Control in Taiwan (Taiwan-CDC) routinely
detects many imported dengue cases each year. Thus, Tai-
wan is an ideal place to study the evolution and disper-
sion of DENV that may have different epidemic potential,
particularly in the 1994 and 1998 DHF epidemics in Tai-
wan that coincided with the DHF epidemics in Southeast
Asian countries [21]. Complete genomic sequencing of
DENV-3 strains collected from different geographical
locations and isolation years offers the opportunity to
understand the genetic stasis and possible selection pres-
sure sites in the DENV genome other than within the E
gene.
Methods
Sources of DENV-3 viruses
The blood samples of suspected dengue patients,
obtained from the sentinel hospitals/clinics located in
Tainan, Kaohsiung and Pingtung in southern Taiwan,
were sent to the Infectious Disease Epidemiology Labora-
tory at National Taiwan University (NTU) and Taiwan-
CDC for laboratory confirmation. The study protocol wasVirology Journal 2008, 5:63 http://www.virologyj.com/content/5/1/63
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approved by the College of Public Health Research
Human Subject Ethics Review Committee at NTU. A sus-
pected and confirmed dengue case was defined as previ-
ously described and confirmed by both laboratories
[20,22]. Imported and indigenous dengue cases were
defined based on the patients' travel history to dengue-
endemic or -epidemic countries within 3–14 days before
the onset of the disease.
Due to few DENV-3 epidemics and limited DENV-3 iso-
lates identified before 1998 in Taiwan, we focused our
study on comparing the sequences of different DENV-3
isolates in 1998 and considering various epidemiological
characteristics, including temporal, geographical and host
factors. Six DENV-3 isolates were selected for full-length
sequencing: (1) an isolate from the imported DENV-3
infected case in 1998; (2) an isolate from the indigenous
DF and DHF cases during the 1998 epidemic in Tainan,
Taiwan; (3) the 1998 isolate from a geographical location
in Tainan other than the 1998 epidemic area; (4) an iso-
late from the same geographical location as the 1998
Tainan's epidemic but in 1999; and (5) an isolate from
indoor mosquitoes during the 1998 dengue/DHF epi-
demic in Tainan. The epidemiological characteristics of
these six DENV-3 isolates are summarized in Table 1, and
their GeneBank accession numbers are DQ675520–
DQ675533. In addition to the 1998–99 DENV-3 strains,
four local isolates obtained from Taiwan during previous
years, kindly provided by Taiwan-CDC, were also used for
comparison, including four strains isolated from indige-
nous DF patients during the 1994–95 epidemic in Kaoh-
siung [94TWKH33 (Accession No.: DQ675534),
94TWKH65 (Accession No.: DQ675535), 94TWKH25
(Accession No.: DQ675536), 95TW466 (accession No.:
DQ675519)]. Isolate 95TW466 with low passage history
(two passages in C6/36 cells) was subjected to full-length
genomic sequencing together with the above six isolates
from 1998–99, constituting seven full-length DENV-3
Table 1: Characteristics of the full-length genome sequences of the DENV-3 isolates investigated in this study
Geographic origin Disease Statusa Year Strain Genotype Passage historyb GenBank accession no
Philippines ? 1956 H87 V C6/36, SMB M93130
Guangxi China ? 1980 80-2 V ? AF317645
Thailand DF 1994 C0360/94 II ? AY923865
Thailand DHF 1994 C0331/94 II ? AY876494
Indonesia, Jakarta DF 2004 TB55i I ? AY858048
Indonesia, Jakarta DF 2004 TB16 I ? AY858047
Indonesia, Jakarta DF 2004 PI64 I ? AY858046
Indonesia, Jakarta DF 2004 PH86 I ? AY858045
Indonesia, Jakarta DF 2004 KJ71 I ? AY858044
Indonesia, Jakarta DF 2004 KJ46 I ? AY858043
Indonesia, Jakarta DF 2004 KJ30i I ? AY858042
Indonesia, Jakarta DF 2004 FW06 I ? AY858041
Indonesia, Jakarta DF 2004 FW01 I ? AY858040
Indonesia, Jakarta DF 1998 den3_98 I ? AY858039
Indonesia, Jakarta DF 1988 den3_88 I ? AY858038
Indonesia, Jakarta DF 2004 BA51 I ? AY858037
Indonesia Vaccine candidate Sleman/78 I ? AY648961
Singapore unknown 1995 Singapore 8120/95 II ? AY766104
Indonesia, Sumatra DF 1998 98902890 I ? AB189128
Indonesia, Sumatra DHF 1998 98901517 I ? AB189127
Indonesia, Sumatra DSS 1998 98901437 I ? AB189126
Indonesia, Sumatra DSS 1998 98901403 I ? AB189125
Brazil DSS 2002 BR74886/02 III ? AY679147
Martiniquw ? 1999 D3/H/IMTSSA-MART/1999/1243 III ? AY099337
Sri Lanka ? 2000 D3/H/IMTSSA-SRI/2000/1266 III ? AY099336
Taiwan(Kaoshiung) DF 1995 95TW466 I AP61 2, C6/36 1 In this study
Taiwan Indonesia-imported DF 1998 98TW182 II C6/36 1 In this study
Taiwan (Pingtung) DF 1998 98TW358 II C6/36 1 In this study
Taiwan (Tainan) DF 1998 98TW364 II C6/36 1 In this study
Taiwan (Tainan) DHF 1998 98TW368 II C6/36 1 In this study
Taiwan (Tainan) mosq 1998 98TWmosq II C6/36 1 In this study
Taiwan (Tainan) DF 1999 99TW628 III C6/36 1 In this study
a. ? indicates no information available about the disease status of the patient from which the virus was isolated.
b. ? indicates no information available about the passage history of the virus strains. The C6/36 or AP61 number indicates that the virus strain was 
obtained after the noted number of passages in a C6/36 or AP61 mosquito cell line infected with the original patient's plasma sample. SMB indicates 
suckling mice brain inoculation.Virology Journal 2008, 5:63 http://www.virologyj.com/content/5/1/63
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sequences from Taiwan. The remaining three 1994 DENV-
3 isolates were sequenced only from the 5' NCR to the
COOH-terminus of the E gene region for phylogenetic
analysis.
Viral RNA extraction, RT-PCR and nucleotide sequencing
Acute-phase serum or plasma samples collected from the
dengue patients within seven days after the onset of fever
were used for both virus isolation and molecular diagno-
sis [23,24]. Molecular diagnosis by reverse transcriptase
polymerase chain reaction (RT-PCR) amplification and
subsequent nucleic acid sequencing was performed as pre-
viously described, and a complete list of the PCR and
sequencing primers utilized is available upon request
[25]. The RNA genomic 5' and 3' terminal 20 nucleotide
sequences were not confirmed independently and were
assumed to be of the same length and sequence as the pro-
totype strain H87 in this study.
DENV-3 Viral Sequence and Phylogenetic analysis
A total of 25 complete genomic sequences of DENV-3
strains and one DENV-1 strain A88 (GenBank accession
number AB074761) were aligned using the multiple
sequences alignment ClustalX [26]. These sequences were
further combined with all available sequences of the com-
plete E gene or the complete prM and partial E genes (to
nucleotide position 1140 of the E gene) of DENV-3
deposited in the GenBank database at the National Center
for Biotechnology Information (NCBI). Therefore, the
complete E gene (1479 nt) dataset consisting of a total of
168 sequences and the prM and partial E gene (705 nt)
dataset of a total of 195 sequences were used for phyloge-
netic analysis. A complete list of the sequences along with
associated epidemiological information is available upon
request.
The percentage of sequence similarities and differences
were calculated using Bioedit v3.6 program [27]. Pairwise
comparisons of both nucleotide and amino acid
sequences of DENV-3 isolates were performed using the
program MEGA v3.1 (Molecular Evolutionary Genetics
Analysis, Pennsylvania State University, PA) to determine
the mean and range of the proportional difference (p-dis-
tance) [28]. The model of nucleotide substitution that
best described DENV-3 sequence evolution was identified
using the program Modeltest 3.0 [29]. The resulting most
complex GTR+I+Γ substitution model (general time
reversible model, GTR, a proportion of sites modeled as
invariant, I, variation in rates among sites modeled using
the gamma distribution, Ã) was selected to be the best fit
to the data using the hierarchical likelihood ratio tests
(hLRTs) and Akaine information criterion (AIC). The esti-
mated parameter values from this model were as follows:
relative substitution rates among nucleotides were A ↔ C
= 1.6120, A ↔ G = 9.5789, A ↔ T = 1.7255, C ↔ G =
0.6272, C ↔ T = 29.7738, G ↔ T = 1.0; proportion of
invariable sites (I) was 0.4475; gamma distribution of
among-site rate variation (Ã) was 1.2293; and estimated
base composition of A = 0.3268, C = 0.2145, G = 0.2539,
and T = 0.2048. A maximum likelihood (ML) tree using
these parameter settings was estimated using the DNAML
in Phylip v3.6 package [30]. Bootstrap analysis with 1,000
re-samplings was used to determine confidence values for
groupings within the phylogenetic tree. In addition, a pos-
terior probability distribution tree, generated by imple-
menting the recently developed Bayesian hierarchical
phylogenetic model utilizing a Metropolis-coupled
Monte Carlo Markov Chains (MC)3  algorithm in the
MrBayes program (version 3.1, [31]) was compared with
the evolutionary tree of DENV-3 generated by the ML
method. Indeed, the Bayesian approaches for constructing
phylogenetics have several advantages. First, the primary
analysis often provides faster estimates of the tree and
measurements than the estimates obtained using ML
bootstrapping techniques. Secondly, Bayesian model
selection offers advantages over likelihood methods in
that the competing evolutionary hypotheses need not to
be nested, and it does not rely on standard likelihood
assumptions. In other words, the starting trees in Bayesian
method are randomly chosen, and multiple runs of the
same dataset are generally made with different starting
trees to check convergence of the process. The programs'
default settings for prior probability were used in our
analysis. Bayesian Markov Chain Monte Carlo (BMCMC)
processes, considering the heterogeneity in the evolution-
ary process and thus incorporating a discrete gamma dis-
tribution of four classes of substitution rates across
mutation sites, were run for 500,000 generations. Output
trees were sampled every 100 generations but the first
1,000 trees were discarded before the process reached the
convergence state. The resulting trees were rooted using a
DENV-1 strain A88 isolate as described.
To analyze the selection pressure in DENV-3, the
CODEML program from the PAML package was
employed by implementing a maximum-likelihood
method. This method presents major advantages over
simpler pairwise comparisons in considering the transi-
tion/transversion rate bias, non-uniform codon usage,
and phylogenetic relationships among the sequences
[32]. Positive selection at a small number of codons can
be detected by comparing various models of codon evolu-
tion which differ in how the rates of synonymous (dS)
and nonsynonymous (dN) substitutions (denoted as ω)
are treated among codons or within lineages using likeli-
hood ratio tests. To analyze selection pressures at individ-
ual codons, we compared the M7 and M8 model. In the
M7 model, 10 categories were assigned and estimated
from the data, which specified only neutral evolution;
however, the M8 model allowed positive selection by add-Virology Journal 2008, 5:63 http://www.virologyj.com/content/5/1/63
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ing an 11th codon category at which dN/dS can exceed 1.0.
To examine selection pressures along the lineages, the free
ratio model, which allows certain lineages to have ω ratios
different from the background, was implemented in the
M3 model. Additionally, parameters involving the incor-
poration of classes of codons where ω >1 were used by
comparing the value of the likelihood from M0, in which
the specified neutral evolution of ω is constrained to be
equal to or less than 1 at all codons among all lineages.
The comparison was again assessed using the likelihood
ratio test. If positive selection was found, the Bayesian
method was applied to identify the specific codon that
may have been subjected to positive selection pressure.
Results
Comparison of full-length nucleotide and amino acid 
sequences among DENV-3 strains from Taiwan
We have determined the complete nucleotide sequences
(10,707 nucleotides in length with an ORF of 3,390
amino acids) of the seven different DENV-3 strains from
Taiwan (Table 1). The percentages of nucleotide and
amino acid identities of the entire ORF among these
strains, compared with the prototype DENV-3 strain H87
isolated in the Philippines in 1956, are shown in Table 2.
The indigenous DENV-3 isolates from the 1998 epidemic
area in Tainan City (98TW364 and 98TW368) and from
the sporadic case in Pingtung (98TW358) displayed the
highest similarity, with 99.9% sequence identity in both
nucleotide and amino acid sequences. The 1998 imported
98TW182 strain showed slightly lower nucleotide and
amino acid sequence identity (98%) relative to these 1998
indigenous Taiwanese DENV-3 isolates. The DENV-3 iso-
lates of Taiwan from years other than 1998, including the
1995 Kaoshiung 95TW466 and the 1999 Tainan
99TW628 strains, showed higher sequence diversity com-
pared with the 1998 DENV-3 Taiwan isolates (94% nucle-
otide and amino acid sequence identity), which suggested
that they might have originated from different countries.
Further phylogenetic analysis revealed that these viruses
belong to different genotypes (Genotype I and III; see the
section ''Phylogenetic analysis of DENV-3'' for details).
Compared to the prototype strain H87, several unique
amino acid substitutions that serve as unique signature
sites for each genotype were found within the full
genomic sequences of the selected DENV-3 isolates from
Taiwan or other countries and are listed by the order of the
gene in Table 3. Among those, several substitutions
changed the polarity, charges, or hydrophobicity of these
amino acids, which were present only in genotype III of
DENV-3, including the change from threonine (T) to
alanine (A) at position 112 of the C region, leucine (L) to
histidine (H) at position 55 of the prM region, L to T at
position 301 of the E region, isoleucine (I) to T at position
115 of the NS3 region, and lysine (K) to T and aspartic
acid (D) to asparagine (N) at positions 585 and 835 of the
NS5 region. Similar signature sites experiencing amino
acid property alterations in genotype II included a change
from T to A at position 57 of the prM region, L to serine
(S) at position 178 of the NS1 region, and A to T at posi-
tion 133 of the NS2A region. Thus, our data suggested that
different genotypes of DENV-3 experience different amino
acid changes at both structural and non-structural genes,
and the sites of these substitutions could serve as signature
sites for genotype identification.
Phylogenetic analysis of DENV-3
The phylogenetic trees of DENV-3 were constructed from
the two different nucleic acid dataset alignments: (1) par-
tial sequences of the prM and E gene region (prM/E) from
10 isolates obtained from Taiwan and 185 sequences
available from GenBank; (2) complete E gene sequences
including 168 isolates from both Taiwan and GenBank.
The trees derived from the maximum likelihood method
Table 2: Percentage identity within the entire genome of seven different DENV-3 obtained from Taiwan, as compared with the 
prototype strain H87.
pairwise nucleotide identity (%)
S t r a i n 123 45678
1 H87 - 95.1 95.0 95.0 95.0 95.3 94.9 95.0
2 98TW182 95.0 - 98.0 98.0 98.0 94.2 94.1 98.0
3 98TW358 95.0 98.0 - 99.9 99.9 94.0 94.2 99.9
4 98TW364 95.0 98.0 100.0 - 99.9 94.0 94.2 99.9
5 98TW368 95.0 97.9 99.9 99.9 - 94.0 94.2 99.9
6 95TW466 95.3 94.0 93.8 93.8 93.8 - 93.9 94.0
7 99TW628 94.8 93.9 94.0 94.0 94.0 93.8 - 94.2
8 98TWmosq 94.9 97.9 99.9 99.9 99.9 93.8 94.0 -
pairwise amino acid identity (%)
The upper-right matrix corresponds to nucleotide sequences and the lower-left matrix to the amino acid sequences.Virology Journal 2008, 5:63 http://www.virologyj.com/content/5/1/63
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Table 3: Description of amino acid differences among the selected DENV-3 from Taiwan and other countries as compared to 
reference strain H87
Geno V V I I I I II II II II II III III III III
Strain* H87 80-2 Ind88 Ind04 TW95 Ind98 Tha94 Sing95 Tw182 Tw358 Tw368 TW99 Martini SriLan Brazil
Year 56' 80' 88' 04' 94' 98' 94' 95' 98' 98' 98' 99' 99' 00' 02'
Capsid
35** R KKKKK K
65 V I I I
82 K R R R R
97 K R R R R Q
108 M I I I I I
112 T AAA A
prM
55 H L L L L L L L L L
57 T A A A A A
128 L F F F F
Envelope
68 I V V V V V
81 I VVV V
124 S L L P P P P P P P P P
132 H YYYY Y Y
154 E D D D D D
160 A V V V V V
169 A V V V V V V V H T T T
231 R K K K
270 T N N N N N N N N N
301 L S S T T T T
303 T A A A A
383 K NNN
452 I VVV V
479 A V V V V V V
NS1
178 L S S S S S
188 V I I I I I
217 L F F F F F
339 N SSS S
NS2A
37 L FFF F
55 H R R R
133 A T T T T T
153 T M M M
175 I V V V V V V V V V
NS3
115 I TTT T
255 R K K K K
324 D E E E E E
350 E D D D
356 V A A A A A A A
4 5 2 V A AAAAAAA A
589 K R R R R R R
NS4A
89 I V V V V
99 D EEE E
148 V III I
115 V III I
190 L F F F F
NS4B
116 V III I
191 L F F F F
NS5
281 K R R RVirology Journal 2008, 5:63 http://www.virologyj.com/content/5/1/63
Page 7 of 13
(page number not for citation purposes)
and the Bayesian method based on both datasets were
very similar to each other. Thus, only the posterior proba-
bility tree derived from the Bayesian method based on the
complete E gene sequences is shown (Fig 1). The DENV-3
strains isolated in Taiwan during the 1994–1995's out-
break were grouped into genotype I, together with the ear-
lier DENV-3 strains from Southeast Asia, including those
from Indonesia, Malaysia, the Philippines and the South
Pacific islands. However, all the DENV-3 strains isolated
during the 1998 dengue/DHF epidemic in Taiwan were
classified as genotype II, which consists mainly of viruses
from Thailand. Interestingly, the only DENV-3 strain
(98TW182) examined that was imported to Taiwan from
Indonesia in 1998 did not cluster with the other Indone-
sia DENV-3 isolates. It is related closely to the isolate from
Myanmar from 1998, which grouped with the Thailand
isolates into genotype II. Genotype III of DENV-3 consists
of the strains from Sri Lanka, India, Africa and Samoa that
were recently introduced into Central and South America
and caused major DHF epidemics in many countries. The
99TW628 strain, isolated in 1999 from Tainan in Taiwan,
belongs to this genotype. Genotype IV, representing the
earlier American genotype, consists of the isolates from
Puerto Rico in 1963/77 and Tahiti in 1965, and viruses
belonging to this genotype have not been isolated since
the 1970s. Genotype V consists of the 80-2 strain isolated
from China in 1980, the H87 strain isolated from the
Philippines in 1956, and the Japanese isolate from an
imported case in 1977.
Sequence divergence in nucleotide and amino acid 
sequence among various regions of full-length sequences of 
different genotypes of DENV-3
With the lack of full-length sequences of viruses belonging
to old American genotype IV, only four DENV-3 geno-
types, including representatives of genotype I (98TW366),
genotype II (98TW349), genotype III (98TW628) and
genotype V (H87) were compared. The sequence diver-
gences in nucleotide and amino acid were calculated as
the p-distance by adjusting the lengths of different genes
[25,33]. The highest nucleotide diversity was found in the
NS2A gene (mean ± SD: 5.84 ± 0.54), followed by the E
gene (mean ± SD: 5.04 ± 0.32). Similar results were
observed for amino acid diversity, which was also the
highest in the capsid gene (mean ± SD: 3.13 ± 1.15), fol-
lowed by the NS2A gene (mean ± SD: 2.57 ± 0.62) (Table
4).
Analysis of selection pressure among different viral regions 
of DENV-3 full-length sequences
To determine whether higher sequence diversity in certain
genes could be the result of natural selection pressures, we
implemented the M7 and M8 selection models to deter-
mine whether positive selection pressure among all
codons from the full-length DENV-3 sequences could be
detected by using the CODEML program from PAML [32].
The results suggested that both structural and non-struc-
tural genes of DENV-3 were under neutral selection.
Although the E gene showed positive selection (ω = 2.15)
with statistical significance (p = 0.01) when using the
larger dataset with 73 sequences, no specific site with pos-
itive selection could be detected. To further examine the
selection pressure along the lineage, genotype I, II, III and
V, based on the phylogenetic tree of the full-length
sequences (Fig 2), were examined separately using the M3
model. The results are summarized in Table 5. Although
there were positive selection pressures detected in the C
and NS4B genes of genotype I, and in the E, NS1 and NS3
genes of genotype II, only the NS1 gene of genotype II
showed statistically significant positive selection pressure.
Furthermore, positive selection was detected at position
178 of the NS1 gene (substitution of S for L).
Changes at the 5' and 3' non-coding regions (NCR) and 
secondary structure analysis
Changes occurring in the 5' NCR and 3' NCR were exam-
ined among the DENV-3 viruses isolated in Taiwan and
other countries. In the 5' NCR, positions 62, 90, 109 and
112 had nucleotide changes that were distinguishable for
the specific genotype. Among them, a G to A change at
position 62 was frequently seen in genotype I, a C to T
change at position 90 and a G to A change at position 109
were observed only in genotype II, and an A to G change
at position 112 was present in genotype III. Interestingly,
288 S NNN N
336 M T T T T
422 R K K K K K
585 K TTT T
619 I V V V V V V V
749 R K K K K K K K K K
835 D NNN N
876 N D D D D D
*The GeneBank accession numbers for the strains of DENV-3 compared are H87: M93130; 80-2: AF317645; Ind88: AY858038; Ind04: AY858040; 
TW95: DQ675519; Ind98: AY858039; Tha94: AY923865. Sing95: AY766104; TW182: DQ675520; TW358: DQ675522; TW368: DQ675525; TW99: 
DQ675533; Martini: AY099337; SriLan: AY099336; Brazil: AY679147.
**A blank cell indicates an amino acid identical to that of strain H87.
Table 3: Description of amino acid differences among the selected DENV-3 from Taiwan and other countries as compared to 
reference strain H87 (Continued)Virology Journal 2008, 5:63 http://www.virologyj.com/content/5/1/63
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The Bayesian hierarchical consensus tree showing the phylogenetic relationships between DENV-3 genotypes is based on the  complete E gene sequences (1479 bp) from the 168 DENV-3 strains sampled globally Figure 1
The Bayesian hierarchical consensus tree showing the phylogenetic relationships between DENV-3 genotypes is based on the complete E gene sequences 
(1479 bp) from the 168 DENV-3 strains sampled globally. The names of the DENV-3 isolates refer to the year of isolation and the country of origin. In cases where there 
is more than one isolate from a given country and year, a unique isolate number (or code) is also given. The abbreviations of the names of the countries are: Bangladesh (BD), 
Bolivia (BL), Brazil (Br), Cambodia (Cam), Cuba (Cu), Ecuador (ECU), Indonesia (Indo), Japan (Jap), Martinique (Mart), Mexico (Mexi), Mozambique (Moza), Malaysia (Mal), Myan-
mar (Mya), Nicaragua (Nic), Peru (PR), Puerto Rico (PueR), Philippines (PH), Singapore (Sin), Sri Lanka (SriL), Tahiti (Tah), Thailand (TH), Taiwan (TW), Venezuela (Ven). Boot-
strap values greater than 0.9 based on Bayesian posterior probabilities are shown for key nodes. The major genotypes of DENV-3 are also labeled. The tree was rooted using 
DENV-1 strain A88 (GenBank accession number: AB074761) as the outgroup. Taiwan DENV-3 isolates are marked with a star.Virology Journal 2008, 5:63 http://www.virologyj.com/content/5/1/63
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there was consistently an additional 11-nucleotide
sequence, AGTGAAAAAGA, inserted in the 3' NCR close
to the end of the open-reading frame (ORF) of the DENV-
3 strains isolated in recent years, compared to the proto-
type strain H87. In the 3' NCR, nucleotide changes at posi-
tion 111, 129, 220 and 438 (nucleotide numbering
beginning at 5'-terminus of 3' NCR after the stop codon)
were observed from the strains circulating recently, which
differed from the strain H87. However, none of these
changes had any effect on the predicted secondary struc-
ture of the 3' NCR RNA (data not shown). The putative
genome cyclization sequence UCAAUAUG, located
between nucleotides 38 and 46 of the C gene, was con-
served in all DENV-3 viruses.
Discussion and conclusion
Viral sequence comparisons among isolates from dengue
epidemics of different disease severities may provide valu-
able information regarding the molecular basis of the epi-
demic potential of the virus. DENV-3 re-appeared in 1998
in Taiwan and caused the DF/DHF epidemic in Tainan
City after its first introduction in 1994 [20]. This stimu-
lates a great interest in understanding the molecular rela-
tionship of DENV-3 isolates in Taiwan during inter-
epidemic periods and in comparing them with the strains
circulating globally to understand evolutionary trends
and geographical expansions. Here, we confirmed that the
dengue epidemics in Taiwan were strongly associated with
the globally circulating DENV-3 due to constant introduc-
tion of viruses from Southeast Asia by Taiwanese travelers.
Our data demonstrates the sequence diversity among the
full-genomic sequences of DENV-3 and the positive selec-
tion pressures exerted in different lineages (i.e. genotypes)
at sites in DENV-3 non-structural genes.
Since most Taiwan dengue epidemics were initiated by the
introduction of virus from imported cases [21], phyloge-
netic analysis provides essential information to under-
stand the history and origin of all Taiwan DENV-3 isolates
originating in other countries (Fig. 1). The high nucle-
otide sequence identity (> 99.8%) among the strains iso-
lated in 1998 indicates that they were from a single origin
and further spread to different townships, such as Ping-
tung (ID#98TW358). The only 1998 imported DENV-3
isolated from a traveler who had recently visited Indone-
sia was more closely associated with the genotype II iso-
lates from Myanmar and older isolates from Thailand.
This virus differed from the virus isolated during the 1998
Tainan outbreak, which might suggest that multiple gen-
otypes of DENV-3 circulated in Indonesia. This observa-
tion is consistent with a previous study indicating that at
least two subtypes of DENV-3 were present in Indonesia
[18]. The phylogenetic analysis also suggested that a sin-
gle 1999 isolate (ID#99TW628) from the same location as
the 1998 epidemic was grouped together with the geno-
type III Sri Lanka isolates. Additional DENV-3 isolates
from the first DENV-3-caused DHF outbreak in Taiwan
(1994–1995) were grouped into genotype I. All these
results implicated that repeated introductions of different
genotypes of DENV-3 into Taiwan since 1994 were impor-
tant causes of dengue epidemics, and that DENV-3 was
not endemic in Taiwan. This situation may be similar in
the subtropical region of China. Our country initiated air-
port fever screening during the severe acute respiratory
syndrome (SARS) outbreak in 2003–04, and it success-
fully identified 40 confirmed, imported dengue cases
[22]. Airport fever screening can thus quickly identify
imported dengue cases, and may prevent a significant
number of dengue outbreaks that would have been initi-
ated by imported index cases. However, its cost-effective-
ness in preventing any dengue epidemics in Taiwan will
need to be evaluated in the future.
Table 5: Positive selection and relevant parameter values among 
different genomic regions of full-length DENV-3 sequences
Gene dN/dS
Genotype I Genotype II Genotype III Genotype V
Capsid 5.68 0.00001 0.05 0.00001
prM 0.00001 0.14 0.00001 0.00001
E 0.02 999 0.03 0.097
NS1 0.00001 18.2* 0.02 0.66
NS2A 0.00001 0.00001 0.02 0.08
NS2B 0.00001 0.00001 0.00001 0.00001
NS3 0.008 999 0.007 0.04
NS4A 0.04 0.00001 0.08 0.00001
NS4B 19.37 0.00001 0.00001 0.1
NS5 0.00001 0.008 0.018 0.00001
*p < 0.05 with statistical significance
Table 4: Comparison of sequence diversity (p-distance, %) of full-length genomic sequences among different genotypes of dengue virus 
type 3
Capsid prM E NS1 NS2a NS2b NS3 NS4a NS4b NS5
nucleotide 3.24 ± 0.54 4.37 ± 0.52 5.04 ± 0.32 4.37 ± 0.39 5.84 ± 0.54 4.02 ± 0.59 4.55 ± 0.30 4.21 ± 0.54 3.85 ± 0.41 4.23 ± 0.23
Amino 
acid
3.13 ± 1.15 1.41 ± 0.53 1.60 ± 0.34 1.54 ± 0.36 2.57 ± 0.62 0.54 ± 0.18 0.99 ± 0.24 1.33 ± 0.53 0.85 ± 0.31 1.17 ± 0.20Virology Journal 2008, 5:63 http://www.virologyj.com/content/5/1/63
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With different DENV-3 genotypes imported into Taiwan
from Southeast Asia and other parts of the world, this
virus collection provides an excellent opportunity to
examine the sequence diversity of different genes of the
full-length DENV-3 viral RNA genome for genotypes other
than genotype IV. The highest p-distance of nucleotide
diversity of the full-length genomes occurred for the NS2A
gene (5.84% ± 0.54%), followed by the E gene (5.04% ±
0.32%). In contrast, the highest p-distance of amino acid
diversity of the full-length genomes occurred for the cap-
The Maximum likelihood phylogenetic tree shown here is based on the complete genomic sequences of 25 DENV-3 strains  available from GenBank Figure 2
The Maximum likelihood phylogenetic tree shown here is based on the complete genomic sequences of 25 
DENV-3 strains available from GenBank. The tree was rooted using DENV-1 strain A88 (GenBank accession number: 
AB074761) as the outgroup. The major amino acid changes along lineages within genotype I and II are also labeled. Taiwan 
DENV-3 isolates are marked with a star.Virology Journal 2008, 5:63 http://www.virologyj.com/content/5/1/63
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sid gene (3.13% ± 0.96%), followed by the NS2A gene
(2.57% ± 0.62%). This observation is consistent with the
previous analysis in DENV-1, DENV-3 and DENV-4
[16,34], although the precise cause of the increased rate of
amino acid change in the NS2A gene is unknown. A sim-
ilar observation could also be made while analyzing the
full genomic sequences of West Nile virus (WNV) isolated
from different animal species [35]. The flavivirus NS2A, a
protein important for viral replication and particle forma-
tion [12], is cleaved by viral serine protease. A mutation at
the basic P1 cleavage site residue in NS2A blocks this
processing event and is lethal for virus production while
still allowing RNA replication [36,37]. Furthermore, this
basic residue in NS2A and an acidic residue in NS3 are
important determinants for virus assembly and/or release
[38]. Although the relative high sequence diversity of the
NS2A gene of DENV-3 may be due to the lesser structural
constraint required for NS2A, it is possible that positive
selection pressures may be exerted on this gene. Especially
in light of recent studies, NS2A together with NS4B and
NS4A were identified as dengue virus-encoded proteins
that could antagonize the interferon (IFN) response dur-
ing viral infection [39,40]. Our analysis didn't detect any
selection pressure exerted on the NS2A gene probably due
to the small sample size; future studies will be needed to
focus the selection pressure analysis on non-structural
proteins and DENV evolution.
Several evolutionally conserved amino acid changes are
preserved, which are unique in different DENV-3 geno-
types (Table 3). These substitutions resulted in changes of
its polarity, hydrophobicity or charge. Especially notable
was the change from L to S at position 178 of the NS1
region, which is an amino acid substitution unique to
genotype II. This might be the result of positive selection
within the lineage of genotype II but not other genotypes.
All DENV-3 isolates from Thailand belong to genotype II,
and interestingly, based on a previous publication [16],
strains of DENV-3 isolated prior to 1992 in Thailand may
have been replaced by two new locally evolving strains.
This could be a sign of a new genotype evolving in Thai-
land; however, most of the mutations or substitutions
occurring were deleterious and a purifying selection of
DENV-3 was suggested [16]. It is very likely that the previ-
ous analysis focused on only the E protein gene. Deter-
mining the possibility of a positive natural selection site
in the non-structural genes of the new Thailand lineage
will require further study. A number of T- and B-cell
epitopes are present on the non-structural proteins, espe-
cially the NS1 gene [41-43]. Even though the biological
significance of the L to S change at position 178 of the
NS1 region is unclear, growing evidence supported by in
vitro and in vivo studies suggest that there are certain evo-
lutionary forces acting on the NS1 gene shaping the gene
flow of the dengue viral population, which might differ
during viral replication in mammalian and mosquito cells
[44,45]. This is the first time that a positive selection pres-
sure site was detected in a non-structural protein in
DENV-3 and its importance together with its functional
relevance to epidemic severity will need to be examined
with a larger sample size.
The global distribution of different genotypes of DENV-3
indicates that they originated in Southeast Asia; these gen-
otypes demonstrated higher epidemic potential with
regards to severe DHF epidemics in Sri Lanka, Central and
South America [46,47]. Genotype III, once its transmis-
sion cycle was established locally, soon resulted in DHF
epidemics regardless of an increase in virus transmission
or a change in circulating serotypes [7,14], supporting the
hypothesis that virus strain is an important risk factor for
DHF [48,49]. Two sub-lineages (isolated before and after
1989) existed within the DENV-3 genotype III strains
from Sri Lanka, and the viruses isolated after 1989 were
associated with the DHF epidemic [7]. We found that the
strain isolated in 1999 from a indigenous dengue patient
(99TW628) that did not lead to a large-scale epidemic of
DF or DHF was more closely related to the lineage of the
DENV-3 genotype III Sri Lankan strain isolated before
1989. Similarly, in Indonesia two sub-lineages of DENV-
3 were present (isolated before and after 1998), and a
greater DHF epidemic, especially in adult cases, was
caused by the DENV-3 strains isolated after 1998 [50]. The
DENV-3 strain isolated in Taiwan during the DHF out-
break in 1994 was actually more closely related to the old
Indonesian strain of genotype I from 1976–78. While it is
currently unknown how the different sub-lineages within
each genotype are associated with different DHF epidemic
potential, a recent publication suggested that changing
serotype prevalence could lead to differential susceptibil-
ity to cross-reactive immune responses [16]. Furthermore,
Wearing et al suggested that both vector and short-termed
host cross-immunity are two factors responsible for den-
gue epidemics [51]. It would be necessary to strengthen
comprehensive dengue virological surveillance, especially
in those endemic and hyper-endemic areas/countries, to
monitor the emergence of DENV strains with epidemic
potential for better epidemic prevention and vaccine
development.
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